The North American Coronary Stent Market was worth USD 2.5 billion in 2016 and estimated to be growing at a CAGR of 7.3%, to reach USD 3.56 billion by 2017- 2021.
The North America Coronary Stent Market was worth USD 2.5 billion in 2016 and estimated to be growing at a CAGR of 7.3%, to reach USD 3.56 billion by 2021. A stent is a metal or plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open, and stenting is the placement of a stent.
There is a wide variety of stents used for different purposes, from expandable coronary, vascular and biliary stents, to simple plastic stents used to allow the flow of urine between kidney and bladder.
Major factors driving the growth of this market include technological advancements, increasing number of coronary related procedures, increasing demand for minimally invasive procedures, and rising geriatric population.
Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market. However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.
To view full report: www.marketdataforecast.com/market-…tent-market-2699/
The market for Coronary Stent is broadly categorized into type, mode of delivery, material type and End user. By type, the market is further segmented into bare metal stents, drug eluting stemts and bioabsorbable stents.
The market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue.
By mode of delivery, it is further classified into balloon expandable stents and self-expanding stents. By material, market is analysed under metallic stents and other stents.
By end user, the market is divided into hospitals, cardiac centres and ambulatory surgical centres. On the basis of geography, the global market is analysed under various regions namely U.S.A and Canada.
North America is dominating the global market. U.S.A is accounting for a major share in the regional market.
- Mode of delivery
- End user
Key players in this market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), BIOTRONIK SE & Co.
KG (Germany), B. Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany).
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!